MICHELLE LE: Open Payments
NPI 1346905171 · DOWNEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,851 in 64 payments from 24 companies in 2025. Trend: 2023 $106 · 2024 $1,195 · 2025 $1,851
Food & beverage: $1,725Education: $126
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $255 |
| Merck Sharp & Dohme LLC | 9 | $242 |
| PFIZER INC. | 10 | $201 |
| Novartis Pharmaceuticals Corporation | 6 | $179 |
| PUMA BIOTECHNOLOGY, INC. | 4 | $111 |
| Lilly USA, LLC | 3 | $102 |
| SOBI, INC | 1 | $101 |
| SEAGEN INC. | 1 | $93 |
| Daiichi Sankyo Inc. | 3 | $86 |
| BeOne Medicines USA, Inc. | 3 | $75 |
Products named: KEYTRUDA, RYBREVANT, KISQALI, NERLYNX, VERZENIO, Vonjo, BRUKINSA, ADCETRIS.
Industry payments across CA — which companies pay providers there.
